Introduction: Postoperative pancreatic fistula (POPF) remains the most serious complication of pancreatoduodenectomy (PD), which justifies the search for alternatives to reinforce pancreaticojejunal anastomosis (PJA). Objective: To evaluate the effect on postoperative results and on the cost-effectiveness of using synthetic cyanoacrylate glue in PJA after PD. Methods: Prospective, randomized study, including 63 consecutive patients undergoing PD divided into 2 groups: GWC (group with cyanoacrylate), 30 patients using synthetic cyanoacrylate glue in the PJA, and 33 patients without application (GWOC, group without cyanoacrylate). The variables studied were organized in epidemiological, clinical, and laboratory terms, with emphasis on the incidence of pancreatic fistula, grouped according to the definition of the International Study Group on Pancreatic Fistula, and the postoperative complications were categorized according to the Clavien-Dindo classification. In addition, the costs of hospital treatment were verified using cost-effectiveness ratio (CER) and incremental (ICER) analysis. Results: In the GWC, the incidence of POPF was significantly lower (16.7%) compared to the GWOC (39.7%); P=0.046, as well as the length of hospital stay in days (11.3 GWC, 16.2 GWOC; P=0.04) and the costs of hospital stay (GWOC US$ 3068,95; GWC US$ 2159,01; P=0.0413). In the cost-effectiveness analysis, we found an ICER of US$ -35,65, and in the total sample an ICER of -US$ -1513,13. Conclusions: The use of synthetic cyanoacrylate glue to reinforce the PJA in patients undergoing PD under the conditions studied improved clinical postoperative results and hospitalization costs which justifies expanding studies, especially in circumstances of greater risk for postoperative pancreatic fistula.
Introduction: The advantages of single-stage treatment of cholecystocholedocholithiasis are well established, but the conditions for carrying out treatment on an outpatient basis require a review of concepts and practices of medical corporations. Objective: To evaluate the practice of treating cholecystocholedocholithiasis by laparoendoscopy on an outpatient basis with cost analysis. Method: A retrospective study was conducted on patients with cholecystocholedocholithiasis treated by combined laparoscopic cholecystectomy and endoscopic choledocholithotomy from January 2015 to January 2019. After collecting data from physical and digital medical records, the patients were divided into two groups—AR (n = 42)—ambulatory regimen and HR (n = 28)—hospitalization regimen—which were compared in terms of demographic, clinical and treatment variables and their results, as well as in terms of costs. Results: The mean age of the AR group was lower than that of the HR group and the physical status of the AR patients was better when assessed according to the American Society of Anesthesiologists (ASA) (p = 0.01). There was no difference between groups regarding the risk of choledocholithiasis (p = 0.99). For the AR group, the length of stay was shorter: 11.29 h × 65.21 h (p = 0.02), as was the incidence of postoperative complications assessed by applying the Clavien–Dindo classification: 3 (7.1%) × 11 (39.2%) (p < 0.01). The total mean costs were higher for the HR group (USD 2489.93) than the AR group (USD 1650.98) (p = 0.02). Conclusion. Outpatient treatment of cholecystocholedocholithiasis by laparoendoscopy is safe and viable for most cases, has a lower cost and can support the reorientation of training and practice of hepatobiliary surgeons.